.svg)
NAD+ IV Therapy delivers NAD+ intravenously. NAD is a coenzyme involved in cellular redox reactions and energy metabolism, but clinical evidence for IV NAD+ as a wellness, cognitive, sleep, detoxification, or anti-aging treatment remains limited.
Because IV NAD+ products used in wellness practice are generally compounded, product source, sterility, ingredient suitability, dose, and infusion rate matter. Medical context matters more than assuming that IV delivery guarantees a clinical benefit.
AlyneMD treats NAD+ IV as an elective medical infusion with uncertain wellness benefits—not as a proven treatment for cognition, sleep, metabolism, or aging. We focus on candidacy, source quality, infusion tolerability, and informed consent rather than promising cellular rejuvenation or detoxification.
NAD+ IV Therapy: What Patients Should Know
NAD+ has an important biological role, but IV wellness protocols do not have the same evidence base as FDA-approved treatments for specific diseases. The decision should include evidence limitations, product quality, infusion risks, alternatives, and cost.
NAD+ IV Infusion, Tolerability & Monitoring
.svg)
.svg)
Why Choose AlyneMD
What to Expect From Your Treatment Journey
Pre-Treatment
Post-Treatment
Mild fatigue may occur.
How AlyneMD Approaches NAD+ IV Therapy
Source & Sterility First
Dose & Infusion Rate Matter
Evidence & Alternatives
Frequently Asked Questions
NAD is a coenzyme required for many cellular redox and metabolic reactions. That biological role is well established; what is not established is that an IV NAD+ wellness infusion reliably improves energy, cognition, sleep, detoxification, or aging outcomes in otherwise healthy adults.
There is no validated timeline for a clinical wellness response. Some patients report subjective changes after infusion, but those experiences should not be treated as proof of a predictable therapeutic effect.
No IV infusion is risk-free. Risks include IV-site complications and infusion reactions. Compounded NAD+ products are not FDA-approved, and FDA has reported severe chills, shaking, vomiting and fatigue in patients who received injectable NAD+ associated with unsuitable ingredients or excessive endotoxin. Product source and sterile-compounding quality matter.
NAD+ drips run slower than standard IVs. Sessions typically take 60–120 minutes depending on the dosage and your tolerance.
Cost depends on the prescribed dose, infusion time, product source, and whether treatment is a one-time infusion or part of a planned series. AlyneMD reviews the expected cost before treatment begins.
No FDA-approved NAD+ IV product is indicated for anti-aging, brain fog, sleep enhancement, detoxification, or general wellness. NAD+ infusions offered for these purposes are generally compounded, so patients should understand the difference between a compounded preparation and an FDA-approved drug.
Clinical evidence is currently insufficient to promise that NAD+ IV improves brain fog or sleep. Persistent cognitive or sleep symptoms deserve evaluation for more established causes and treatments rather than assuming low NAD+ is the explanation.
.svg)
